Pharmaceutical Technology

FEBRUARY 24, 2023

The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation.

Pharma 64

Pharma Medicine Competition Food 64

European Pharmaceutical Review

DECEMBER 19, 2022

She has experience on issues arising during the lifecycle of medicinal products, including optimisation of IP regulatory rights, advertising, product liability, competition and market access issues. Directive 2001/83 (as amended). The Impact of Biosimilar Competition in Europe, IQVIA, December 2021. EMA Biosimilars Q&A.

Medicine 52

Medicine Biopharma Safety Food 52

Evolve Your Success

JUNE 21, 2022

Pharma Sales To Med Device CEO: The Jeff Smith Story Part 1. For context, Cyber Tuesday, which is the Tuesday after Thanksgiving was developed in 2001. You started in pharma. With the course of a whole day of travel, you quickly realize that’s the competition. My competition was better. Listen to the podcast here.

Sales 52

Sales Pharma Pharmaceutical Sales Medical 52

European Pharmaceutical Review

SEPTEMBER 14, 2023

For both small biotechs and large pharma, economic uncertainty is rising, intensifying decision-making risks associated with early drug discovery efforts, clinical trials, quality and manufacturing process execution, and navigating the approval process. In 2001 and 2007, through 2009, the economy was hit hard.

Manufacturing 80

Manufacturing Engineering Management Pharmaceutical 80

Pharmaceutical Technology

FEBRUARY 13, 2023

The first concept for a PROTAC was published in 2001, and recently these protein degraders have gained rapid momentum as a promising novel modality. By this same virtue, PROTACs are able to degrade previously undruggable targets, which provides a major competitive advantage for this modality if shown to be true.

Competition 59

Competition Safety Patients Pharmaceutical 59

Pharmaceutical Technology

JULY 10, 2008

“To remain at the forefront of medical research, pharma needs a faster, more predictive way of testing molecules before they go into humans,” says Steve Arlington, global life sciences industry advisor leader at PwC. “There is a real threat the pharmaceutical R&D industry could move offshore.”

Food and Drug Administration 52

Food and Drug Administration Medicine Pharmaceutical Government 52